Page last updated: 2024-08-23

elliptinium and HIV Coinfection

elliptinium has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanquet, D; Hallard, M; Mathé, G; Morette, C; Pontiggia, P; Triana, K	1

Reviews

1 review(s) available for elliptinium and HIV Coinfection

Article	Year
Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1998, Volume: 52, Issue:9 Topics: Acriflavine; Anti-HIV Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ellipticines; HIV Infections; Humans; Treatment Outcome; Zidovudine	1998

Article

Year

Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1998, Volume: 52, Issue:9

Topics: Acriflavine; Anti-HIV Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ellipticines; HIV Infections; Humans; Treatment Outcome; Zidovudine

1998